Evidence map›Paper›PMID 26468188›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.

Tuan Trang, Ream Al-Hasani, Daniela Salvemini, Michael W Salter, Howard Gutstein, Catherine M Cahill

Abstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Opioid system and related ligands: from the past to future perspectives.Journal of anesthesia, analgesia and critical care · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Opioid-Induced Hyperalgesia and Tolerance Are Driven by HCN Ion Channels.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tuan TrangDepartments of Comparative Biology and Experimental Medicine and Physiology and Pharmacology, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada, trangt@ucalgary.ca cmcahill@uci.edu.
Ream Al-HasaniDepartments of Anesthesiology and Anatomy-Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110.
Daniela SalveminiDepartment of Pharmacological and Physiological Science, St. Louis University School of Medicine, St. Louis, Missouri 63104.
Michael W SalterNeurosciences and Mental Health Program, Hospital for Sick Children, Toronto, Ontario M5G 0A4, Canada.
Howard GutsteinMD Anderson Cancer Center, Houston, Texas 77030, and.
Catherine M CahillDepartment of Anaesthesiology and Perioperative Care, University of California Irvine, Irvine, California 92697 trangt@ucalgary.ca cmcahill@uci.edu.ORCID http://orcid.org/0000-0001-7009-9083

Funding

The role of RTK signaling in opioid toleranceR01DA036680 · NIDA · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GUTSTEIN, HOWARD B · 2014 to 2018
$1.8M
A3AR agonists to prevent chemotherapy-induced painful peripheral neuropathyR01CA169519 · NCI · SAINT LOUIS UNIVERSITY · PI SALVEMINI, DANIELA · 2013 to 2017
$1.5M
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSR00DA038725 · NIDA · ST. LOUIS COLLEGE OF PHARMACY · PI AL-HASANI, REAM · 2017 to 2019
$747k
Preserving opioid analgesia using a novel adenosinergic approachR21DA040305 · NIDA · SAINT LOUIS UNIVERSITY · PI SALVEMINI, DANIELA · 2015 to 2016
$377k
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSK99DA038725 · NIDA · WASHINGTON UNIVERSITY · PI AL-HASANI, REAM · 2015 to 2016
$280k
Canadian Institutes of Health Research MOP123298Canadian Institutes of Health Research MOP123307Canadian Institutes of Health Research MOP133523NCI NIH HHS R01 CA169519NIDA NIH HHS 1R01DA036680-01NIDA NIH HHS DA038725NIDA NIH HHS K99 DA038725NIDA NIH HHS R00 DA038725NIDA NIH HHS R01 DA036680NIDA NIH HHS R21 DA040305
6 · The paper itself

Abstract

Treating pain is one of the most difficult challenges in medicine and a key facet of disease management. The isolation of morphine by Friedrich Sertürner in 1804 added an essential pharmacological tool in the treatment of pain and spawned the discovery of a new class of drugs known collectively as opioid analgesics. Revered for their potent pain-relieving effects, even Morpheus the god of dreams could not have dreamt that his opium tincture would be both a gift and a burden to humankind. To date, morphine and other opioids remain essential analgesics for alleviating pain. However, their use is plagued by major side effects, such as analgesic tolerance (diminished pain-relieving effects), hyperalgesia (increased pain sensitivity), and drug dependence. This review highlights recent advances in understanding the key causes of these adverse effects and explores the effect of chronic pain on opioid reward. SIGNIFICANCE STATEMENT: Chronic pain is pervasive and afflicts >100 million Americans. Treating pain in these individuals is notoriously difficult and often requires opioids, one of the most powerful and effective classes of drugs used for controlling pain. However, their use is plagued by major side effects, such as a loss of pain-relieving effects (analgesic tolerance), paradoxical pain (hyperalgesia), and addiction. Despite the potential side effects, opioids remain the pharmacological cornerstone of modern pain therapy. This review highlights recent breakthroughs in understanding the key causes of these adverse effects and explores the cellular control of opioid systems in reward and aversion. The findings will challenge traditional views of the good, the bad, and the ugly of opioids.

Indexed as

Analgesics, OpioidAnimalsCentral Nervous SystemChronic PainHumansModels, BiologicalPapaverAnalgesics, Opioid

Identifiers

PMID26468188
PMCPMC4604226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.